GV 2021 Gp, L.P., 10% Owner at Prime Medicine, Inc. (PRME), sold 157,227 shares at $16.70 ($1.8M) on 2023-06-05, disclosed to the SEC on 2023-06-07.
Scheduled sale ($1.8M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 22,434 | $0 | 0.0% |
| 2 | $16.70 | 22,434 | $375K | 21.2% |
| 3 | $16.70 | 22,434 | $375K | 21.2% |
| 4 | $0.00 | 29,975 | $0 | 0.0% |
| 5 | $17.02 | 29,975 | $510K | 28.8% |
| 6 | $17.02 | 29,975 |
| $510K |
| 28.8% |
| Total | $11.26 avg | 157,227 | $1.8M | 100% |
| Filing → |
| PRME | SELL | 2023-06-09 | $586K | — | Filing → |
| PRME | SELL | 2023-05-22 | $2.5M | — | Filing → |
| PRME | SELL | 2023-05-10 | $11.9M | — | Filing → |